A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination…

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 260 followers.

[Full text] A Phase II single-arm trial of palonosetron for the prevention of acut | TCRM @DovePress https://t.co/F5eNFjJYmw

Reply Repost Favourite